Cancer medicine generates enormous revenues but marginal benefits for patients...
Despite flimsy evidence, trying these drugs in humans is the only way to know if they will work against COVID-19
The promise of host response profiling
For some of the most common cardiac conditions, medication is a solid alternative
A growing medical subspecialty focuses on the nexus between cancer and heart disease
Next-generation opioids may spring from a tiny fungus protein
The pharmaceutical industry is in a drug-discovery slump. How much can AI help?
Researchers dialed down the default number of opioids in two hospitals’ prescription systems—and doctors ended up prescribing fewer pills. Christopher Intagliata reports.
Dozens of compounds approved for other purposes can kill cancer cells selectively
It comes in many types that each require specialized treatment, and scientists are learning to diagnose different varieties
The first research center of its kind in the country is bringing renewed rigor to the investigation of the drugs’ therapeutic uses
Even combination therapies do not prevent such pathogens from becoming resistant
The pathogen has been newly identified in eight cases of encephalitis in Germany over the past 20 years
Our most powerful painkillers can actually make some patients more sensitive to pain
The most widely used antivenom is not effective against the venom of several common snakes
A Chinese Court jailed He Jiankui for an “illegal medical practice” in editing embryos’ DNA
New therapies for beloved pets are getting developed in hopes of treating humans as well
The first to be approved in the United States, the vaccine protects against the virus responsible for the current outbreak in the Democratic Republic of the Congo...
The technology embeds immunization records into a child’s skin
The proposals, which are still under review, are a step toward allowing drugs to be imported from Canada and other countries